Digital Twins for Predictive, Preventive Personalized, and Participatory Treatment of Immune-Mediated Diseases
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-03 · 43 (3) · 410-416
DOI: 10.1161/atvbaha.122.318331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-03. Verfasst von Mikael Benson. Beteiligte Einrichtung: Medical Digital Twin Research Group, Division of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, St…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Digital twins are computational models of complex systems, which aim to understand and optimize those systems more effectively than would be possible in real life. Ideally, digital twins can be translated to individual patients, to characterize and computationally treat their diseases with thousands of drugs, to select the drug or drugs that cure the patients. The background problem is that many patients do not respond adequately to drug treatment. This problem reflects a wide gap between the complexity of diseases and clinical practice. Each disease may involve altered interactions between thousands of genes that vary between different cell types in different organs. To our knowledge, these altered interactions have not been characterized on a genome-, cellulome-, and organ-wide scale in any disease. Thus, clinical translation of the digital twin ideal for predictive, preventive, personalized and participatory treatment involves formidable challenges, which are close to the limits of, or beyond today’s technologies. Here, I discuss recent developments and challenges in relation to that ideal focusing on immune-mediated inflammatory diseases, as well as examples from other diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Digital Twin Research Group, Division of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Mikael Benson
Zitieren
APA
Benson, M. (2023). Digital Twins for Predictive, Preventive Personalized, and Participatory Treatment of Immune-Mediated Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(3), 410-416. https://doi.org/10.1161/atvbaha.122.318331
Vancouver
Benson M. Digital Twins for Predictive, Preventive Personalized, and Participatory Treatment of Immune-Mediated Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(3):410-416. doi:10.1161/atvbaha.122.318331
BibTeX
@article{Benson2023,
author = {Benson, Mikael},
title = {Digital Twins for Predictive, Preventive Personalized, and Participatory Treatment of Immune-Mediated Diseases},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {3},
pages = {410--416},
doi = {10.1161/atvbaha.122.318331}
}
EUVIMED